Konkalmatt, P. R., Wang, F., Piras, B. A., Xu, Y., O’Connor, D. M., Beyers, R. J., . . . French, B. A. (2012). AAV9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.
Chicago Style CitationKonkalmatt, Prasad R., et al. AAV9 Administered Systemically After Reperfusion Preferentially Targets Cardiomyocytes in the Infarct Border Zone With Pharmacodynamics Suitable for the Attenuation of Left Ventricular Remodeling. 2012.
Cita MLAKonkalmatt, Prasad R., et al. AAV9 Administered Systemically After Reperfusion Preferentially Targets Cardiomyocytes in the Infarct Border Zone With Pharmacodynamics Suitable for the Attenuation of Left Ventricular Remodeling. 2012.